HCA Holdings (HCA) PT Raised to $150 at Oppenheimer
Tweet
Share
E-mailGet Alerts HCA Hot Sheet
Price: $432.60 --0%
Rating Summary:
24 Buy, 11 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 7 | New: 26
Rating Summary:
24 Buy, 11 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 7 | New: 26
Join SI Premium – FREE
Oppenheimer analyst Michael Wiederhorn raised the price target on HCA Holdings (NYSE: HCA) to $150.00 (from $142.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Assumes HCA Healthcare Inc (HCA) at Market Perform
- Sino Biopharmaceutical Ltd. (1177:HK) (SBMFF) PT Lowered to HK$8 at HSBC
- Livzon Pharmaceutical Group Inc. (1513:HK) (LVZPF) PT Lowered to HK$22.30 at HSBC
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
